Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like CHMP PROM agenda for the meeting on 6 December 2021 Agenda – CHMP agenda of the 18-21 July 2022 meeting Agenda – PDCO agenda of the 20-23 April 2021 meeting
